• The combined company pairs the only research-validated nutrition AI with the leading insurance-covered dietitian and GLP-1 platform in the U.S.

Bengalaru, India:  Healthify, India’s leading AI powered health and wellness platform and Berry Street, the leading nutrition care company, today announced they have merged, creating the most advanced insurance-covered AI metabolic health platform in the U.S.

The combined company will be led by Noah Kotlove and Tushar Vashisht as Co-CEOs. In the U.S., the company will continue to operate under the Berry Street brand. Outside the U.S., including in India and other markets where Healthify has established a strong consumer presence, the Healthify brand will remain.

One in three Americans now turns to AI for health guidance, double the share from just a year ago, and the number seeking diet and weight loss support is growing rapidly alongside the GLP-1 boom. But most of that guidance comes from general-purpose AI tools that lack clinical credibility and evidence-based outcomes.

By combining, the two companies will be better able to deliver expert metabolic care that’s AI-powered, clinician-backed, and covered by insurance in the U.S.

Healthify’s platform, recognised by OpenAI for its innovative approach, has been honed on hundreds of millions of real dietitian-to-patient interactions, enabling it to synthesise signals across nutrition, sleep, stress, and weight in real time. As a market leader in India, Healthify has served more than 45 million users across more than 20 cultures, and its GLP-1 weight management initiative, which includes a patient support program with Novo Nordisk, is Healthify’s fastest-growing offering.

Berry Street delivers personalised, evidence-based metabolic care — including prescribing GLP-1s when appropriate — through its nationwide network of 2,000-plus clinicians. In most cases, this care is covered by insurance, so people pay little or nothing out of pocket. Berry Street is among the first cohort of CMS’s groundbreaking ACCESS model and has served more than 200,000 patients across all 50 states through collaborations with Amazon, Walmart, and other leading health plans and consumer platforms.

“Healthify’s mission has been to put a dietitian in every human’s pocket.We have spent a decade proving that AI can drive life-changing outcomes at scale,” said Tushar Vashisht, Founder and CEO of Healthify. “Berry Street gives us the clinical backbone and the coverage infrastructure to deliver that promise to the U.S. market at a scale no one has achieved before. This is the combination the industry has been waiting for.”

“One in eight Americans is now on a GLP-1, and it’s just the beginning. The science is clear: these medications are most effective when paired with high-touch clinical oversight and expert nutrition guidance. But for most Americans, that experience has been out of reach,” said Noah Kotlove, Founder and CEO of Berry Street. “Berry Street and Healthify are building a future where everyone has access to care in their pocket 24/7, supported by AI to handle the in-between moments so providers can practice at the top of their license.”

Healthify’s AI platform, Ria, is among the most rigorously validated consumer nutrition AI products. A peer-reviewed study published with Stanford Medical School, the first paper to examine AI-only metabolic health outcomes, demonstrated measurable improvements in weight and metabolic markers among Ria users. Ria’s capabilities are multimodal and multilingual, with patented food-logging technology that can track nutrition from a photograph in under one second, without the user ever opening the app.

Berry Street patients meet synchronously with a care team of registered dietitians, doctors, and nurse practitioners for GLP-1 management and ongoing nutrition therapy. Between visits, patients use the Berry Street app for AI-powered guidance, meal tracking, and integration of health data from wearables and lab results. Berry Street supports more than 30 conditions, ranging from weight loss and diabetes to women’s health and heart health.

“By pairing AI with a nationwide network of expert clinicians, Healthify and Berry Street are building the platform that will redefine metabolic care, giving everyone access to daily nutrition guidance and expert dietitian advice,” said Vinod Khosla, founder of Khosla Ventures.

“Healthify was built to serve the underserved consumer, first in India, then across the world. Together with Berry Street’s leading clinician network, this merger is proof that technology and clinical expertise can tackle the world’s most complex healthcare challenges,” said Biju Mohandas, Partner and Global Healthcare Lead, LeapFrog Investments.

Healthify is an AI-powered nutrition platform whose AI product, Ria, delivers clinician-validated, personalised metabolic health guidance at scale. Backed by a peer-reviewed Stanford study and recognised by OpenAI, Ria synthesises signals across nutrition, sleep, stress, and weight to provide always-on, culturally-relevant coaching in multiple languages. As a market leader in India, Healthify has served more than 45 million users across more than 20 cultures worldwide. To learn more, visit healthify.com.

Berry Street is the most advanced insurance-covered AI metabolic health platform. Its platform connects patients with an expansive network of Registered Dietitians, physicians, and nurse practitioners for evidence-based nutrition care and GLP-1 therapy. From weight management, diabetes, and heart health to kidney disease, maternal health, and 30+ other conditions, Berry Street’s clinical team delivers personalized interventions tailored to each patient’s unique physiological and psychological needs, improving outcomes and reducing total cost of care. Berry Street works with some of the largest health plans, as well as leading health systems and innovative care management companies to serve diverse populations across all 50 states. Visit berrystreet.com to learn more.

LeapFrog is the pioneer of Profit with Purpose investing. Founded in 2007, its team has backed and built high-growth companies delivering healthcare, financial services and climate solutions that operate across 37 countries. Today, LeapFrog companies reach 622 million people with essential services and grow on average at 22% a year. They also finance or protect 33 million emerging enterprises and support 81 million jobs. Through its private equity funds, LeapFrog has raised billions of dollars from institutional investors worldwide and co-created industry champions across global growth markets. The firm has played a foundational role in what is now the $1.6 trillion impact investing industry, collaboratively creating global organisations and standards. LeapFrog was ranked, alongside Apple and Novartis, by Fortune as one of the top five Companies to Change the World.